Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A New Master Donor Virus for the Development of Live-Attenuated Influenza B Virus Vaccines.

Viruses - 30 Jun 2021

White Chantelle L, Chiem Kevin, Perez Daniel R, Santos Jefferson, Cardenas Garcia Stivalis, Nogales Aitor, Martínez-Sobrido Luis

Abstract excerpt

Influenza B viruses (IBV) circulate annually, with young children, the elderly and immunocompromised individuals being at high risk. Yearly vaccinations are recommended to protect against seasonally influenza viruses, including IBV. Live attenuated influenza vaccines (LAIV) provide the unique opportunity for direct exposure to the antigenically variable surface glycoproteins as well as the more conserved internal...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Dogs
Share to Influenza B virus

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Influenza, Human

Share to Influenza Vaccines

Share to Madin Darby Canine Kidney Cells

Share to Reverse Genetics

Share to Vaccination

Share to Vaccines, Attenuated

Source

Open in PubMed Open full text

Identifiers

PMID: 34208979
DOI: 10.3390/v13071278
PMCID: PMC8310163

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A New Master Donor Virus for the Development of Live-Attenuated Influenza B Virus Vaccines.PMID 34208979Read ↗

Development of an Alternative Modified Live Influenza B Virus Vaccine.Semantic proximity Read ↗

Comparative Study of the Temperature Sensitive, Cold Adapted and Attenuated Mutations Present in the Master Donor Viruses of the Two Commercial Human Live Attenuated Influenza Vaccines.Semantic proximity Read ↗

Mutation E48K in PB1 Polymerase Subunit Improves Stability of a Candidate Live Attenuated Influenza B Virus VaccineSemantic proximity Read ↗

A single amino acid substitution in PB1 of pandemic H1N1 with A/Ann Arbor/6/60 master donor virus mutations as a novel live-attenuated influenza virus vaccineSemantic proximity Read ↗

Genetic mapping of the cold-adapted phenotype of B/Ann Arbor/1/66, the master donor virus for live attenuated influenza vaccines (FluMist).Semantic proximity Read ↗

Reversion of Cold-Adapted Live Attenuated Influenza Vaccine into a Pathogenic VirusSemantic proximity Read ↗

Multiple gene segments control the temperature sensitivity and attenuation phenotypes of ca B/Ann Arbor/1/66.Semantic proximity Read ↗

Live-attenuated influenza virus vaccine strain with an engineered temperature-sensitive and genetically stable viral polymerase variant.Semantic proximity Read ↗

Generation of a recombinant temperature-sensitive influenza D virusSemantic proximity Read ↗

Engineering temperature sensitive live attenuated influenza vaccines from emerging viruses.Semantic proximity Read ↗

FluB-RAM and FluB-RANS: Genome re-arrangement as safe and efficacious live attenuated influenza B virus vaccines.Semantic proximity Read ↗

Alternative Strategy for a Quadrivalent Live Attenuated Influenza Virus Vaccine.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.